IRIS
GALATI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.600
NA - Nord America 485
EU - Europa 228
SA - Sud America 35
AF - Africa 13
OC - Oceania 6
Totale 4.367
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.193
US - Stati Uniti d'America 466
CN - Cina 255
HK - Hong Kong 114
GB - Regno Unito 61
IT - Italia 47
DE - Germania 35
BR - Brasile 24
FI - Finlandia 19
CZ - Repubblica Ceca 15
NL - Olanda 15
CA - Canada 10
PL - Polonia 10
FR - Francia 9
IN - India 9
TR - Turchia 8
MX - Messico 7
ES - Italia 6
VN - Vietnam 6
AU - Australia 5
ZA - Sudafrica 5
CL - Cile 4
AR - Argentina 3
PE - Perù 3
SE - Svezia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BY - Bielorussia 2
JP - Giappone 2
MA - Marocco 2
TH - Thailandia 2
UA - Ucraina 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BF - Burkina Faso 1
BW - Botswana 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GN - Guinea 1
HT - Haiti 1
IQ - Iraq 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KI - Kiribati 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MU - Mauritius 1
MY - Malesia 1
SA - Arabia Saudita 1
UY - Uruguay 1
Totale 4.367
Salva come PNG Salva come JPEG
Città #
Singapore 177
Hong Kong 112
Hefei 103
Ashburn 95
Dallas 70
Beijing 64
Boardman 55
London 48
Shanghai 36
Munich 25
Rome 20
Council Bluffs 17
Los Angeles 16
Brno 15
Seattle 15
San Francisco 13
Santa Clara 11
Turku 11
Amsterdam 10
São Paulo 10
West Jordan 10
Boston 9
New York 9
Warsaw 9
Helsinki 8
Washington 7
Mexico City 6
Pune 6
Sona 5
Toronto 5
Brooklyn 4
Guangzhou 4
Chicago 3
Johannesburg 3
Lima 3
Manchester 3
Montreal 3
Paris 3
Secaucus 3
Stockholm 3
Bangkok 2
Boydton 2
Camden 2
Canberra 2
Central 2
Ho Chi Minh City 2
Melbourne 2
Naples 2
Poplar 2
Suffern 2
Tangshan 2
Tokyo 2
Zhengzhou 2
Almere Stad 1
Alvorada 1
Amman 1
Ankara 1
Atlanta 1
Augusta 1
Baku 1
Bihać 1
Brest 1
Brussels 1
Buffalo 1
Camaçari 1
Cape Town 1
Carney 1
Casablanca 1
Chandigarh 1
Changchun 1
Chennai 1
City of London 1
Cleveland 1
Cold Lake 1
Conakry 1
Concepción 1
Curepipe 1
Curitiba 1
Delmas 1
Esteio 1
Foligno 1
Frankfurt am Main 1
Fuzhou 1
Gaborone 1
Gauteng 1
Genoa 1
Goiânia 1
Haiphong 1
Handan 1
Hangzhou 1
Hanover 1
Helena 1
Hengshui 1
Inhambupe 1
Jinan 1
Joinville 1
Kopavogur 1
Kuala Lumpur 1
Las Vegas 1
Lauro Müller 1
Totale 1.102
Salva come PNG Salva come JPEG
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 206
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 205
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 202
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 200
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 199
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 197
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 191
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 190
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 189
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 187
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 182
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 180
Assessment of liver function by the exhaled breath-print during chronic liver disease 177
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 169
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 135
Diabetes in chronic liver disease: from old concepts to new evidence 104
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 99
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 94
A challenging alfa-fetoprotein in a cirrhotic patient 92
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 89
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 87
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 87
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 82
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 80
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 58
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 36
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 36
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 35
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 34
Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD 33
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 32
Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis 32
Hepatic complications of bariatric surgery : the reverse side of the coin 30
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 30
Lower schooling, higher hepatitis C virus prevalence in Italy: an association dependent on age 29
Surgical complications after resection of adrenal carcinoma 29
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 29
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 28
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 26
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 25
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scan 25
GAS EXCHANGE AND PULMONARY MICROCIRCULATION ABNORMALITIES IN CIRRHOTIC AND NON-CIRRHOTIC CHRONIC LIVER DISEASE PATIENTS FREE FROM HEPATOPULMONARY SYNDROME 25
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 24
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 24
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 23
Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy 22
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 22
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 20
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 19
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis 18
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 17
Totale 4.384
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.426
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 4 0 0 2 0 0 5 0 0 72
2022/202333 6 0 1 1 0 2 9 4 0 1 9 0
2023/2024194 8 13 6 20 13 79 2 13 3 12 7 18
2024/20253.571 35 17 55 9 55 66 51 7 111 183 1.481 1.501
2025/2026503 169 81 112 141 0 0 0 0 0 0 0 0
Totale 4.384